AA
SWTX

ALPS Advisors’s SpringWorks Therapeutics SWTX Stock Holding History

ALPS Advisors’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-52,048
Closed -$2.56M – 1001
2024
Q1 		$2.56M Buy
52,048
+10,715
+26% +$495K 0.02% 314
2023
Q4 		$1.51M Sell
41,333
-4,877
-11% -$127K 0.01% 380
2023
Q3 		$1.07M Buy
46,210
+253
+0.6% +$6.92K 0.01% 424
2023
Q2 		$1.2M Buy
45,957
+4,777
+12% +$126K 0.01% 428
2023
Q1 		$1.06M Sell
41,180
-1,107
-3% -$32.4K 0.01% 458
2022
Q4 		$1.1M Buy
42,287
+15,347
+57% +$378K 0.01% 448
2022
Q3 		$769K Sell
26,940
-2,368
-8% -$67.9K 0.01% 523
2022
Q2 		$722K Sell
29,308
-21,407
-42% -$783K 0.01% 524
2022
Q1 		$2.86M Sell
50,715
-6,275
-11% -$359K 0.03% 166
2021
Q4 		$3.53M Sell
56,990
-3,224
-5% -$213K 0.04% 176
2021
Q3 		$3.82M Sell
60,214
-4,102
-6% -$316K 0.04% 194
2021
Q2 		$5.3M Sell
64,316
-23,915
-27% -$1.82M 0.05% 171
2021
Q1 		$6.49M Buy
88,231
+1,615
+2% +$126K 0.06% 159
2020
Q4 		$6.28M Buy
86,616
+31,757
+58% +$2.04M 0.07% 163
2020
Q3 		$2.62M Sell
54,859
-3,814
-7% -$162K 0.04% 202
2020
Q2 		$2.46M Sell
58,673
-19,510
-25% -$694K 0.03% 215
2020
Q1 		$2.11M Sell
78,183
-8,420
-10% -$275K 0.03% 208
2019
Q4 		$3.33M Buy
+86,603
New +$2.03M 0.03% 188

Other funds holding SWTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

ALPS Advisors's SWTX Position: Q2 2024 in Review

ALPS Advisors sold out of SpringWorks Therapeutics (SWTX) in Q2 2024, closing a stake of 52,048 shares — an estimated $2.56M sold.

ALPS Advisors first reported a position in SWTX in Q4 2019 and held it in 18 quarters. The position peaked at $6.49M in Q1 2021. 209 funds tracked by Wall St. Rank hold SWTX as of Q2 2024.

  • ALPS Advisors reported no remaining SpringWorks Therapeutics position as of Q2 2024 after selling out during the quarter.
  • ALPS Advisors sold 52,048 SpringWorks Therapeutics shares in Q2 2024, an estimated $2.56M.
  • ALPS Advisors first reported a position in SpringWorks Therapeutics in Q4 2019 and held it in 18 quarters.
  • ALPS Advisors's SpringWorks Therapeutics position peaked at $6.49M in Q1 2021.
  • 209 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2024.

Based on ALPS Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.